Saturn V Capital Management LP
Source: SEC Form 13F · as of Mar 2026Saturn V Capital Management LP holds 12 biotech & pharma companies tracked by BioSniper, totaling $328.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$328.9M
| Company | Shares | Value |
|---|---|---|
| ALMSALUMIS INC. | 3,202,075 | $70.5M |
| ABVXAbivax SA | 542,696 | $60.4M |
| PCVXVaxcyte, Inc. | 824,532 | $47.9M |
| PHVSPharvaris N.V. | 1,201,402 | $33.9M |
| JAZZJazz Pharmaceuticals plc | 162,961 | $30.8M |
| IRONDisc Medicine, Inc. | 449,926 | $28.8M |
| COGTCogent Biosciences, Inc. | 626,635 | $24.1M |
| DYNDyne Therapeutics, Inc. | 966,609 | $17.5M |
| IKTInhibikase Therapeutics, Inc. | 3,863,445 | $6.5M |
| ZURAZura Bio Ltd | 739,960 | $4.4M |
| ANROAlto Neuroscience, Inc. | 88,999 | $2.0M |
| MSLESatellos Bioscience Inc. | 350,000 | $2.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.